Larimar Therapeutics, Inc. (LRMR)
4.79
+0.11
(+2.35%)
USD |
NASDAQ |
Apr 02, 16:00
4.775
-0.02
(-0.31%)
After-Hours: 20:00
Larimar Therapeutics Total Liabilities (Quarterly) : 68.37M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vir Biotechnology, Inc. | 259.65M |
| Gossamer Bio, Inc. | 295.01M |
| ImmunityBio, Inc. | 1.001B |
| BioRestorative Therapies, Inc. | 3.723M |
| Iovance Biotherapeutics, Inc. | 214.59M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 146.46M |
| Shareholders Equity (Quarterly) | 78.08M |
| Debt to Equity Ratio | 0.0521 |
| Current Ratio | 2.192 |
| Net Debt Paydown Yield | 0.08% |